The global Biologics Market is estimated to be valued at US$ 401.96 billion in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023-2030.
A) Market Overview:
The biologics market comprises a diverse range of products including monoclonal antibodies, vaccines, cell and gene therapies, and recombinant proteins. These products are derived from living organisms or contain...
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian